Folate-chitosan nanoparticles triggered insulin cellular uptake and improved in vivo hypoglycemic activity
Date
2019
Authors
Journal Title
Journal ISSN
Volume Title
Type
Article
Publisher
Elsevier B.V.
Series Info
International Journal of Pharmaceutics
571
571
Scientific Journal Rankings
Abstract
The aim of this study was to prove a prolonged control of glucose levels, in rats, by the oral use of insulin folate-chitosan nanoparticles (FA-CS NPs). It was possible to prepare positively charged NPs with an average particle size of 288 � 5.11 nm and >80% entrapment efficiency. The system was able to enhance the stability of insulin in presence of GIT enzymes, with less than 10% release at pH 1.2 and an 8 hr released amount of 38.92 � 4.52% in PBS pH 7.4. A 5 fold enhancement in insulin intestinal permeability and cellular uptake over insulin solution was proven. The cellular uptake pathways was found to occur by several mechanisms. Besides, cell compatibility and absence of histopathological alterations was also demonstrated. Finally, a controlled blood glucose level for 8 h in rats. These results anticipated FA-CS NPs as a promising oral insulin candidate. � 2019 Elsevier B.V.
Description
Scopus
MSA Google Scholar
MSA Google Scholar
Keywords
Cellular uptake, Chitosan, Controlled blood glucose, Folic acid, Insulin, Oral delivery, antidiabetic agent, chitosan nanoparticle, folate chitosan nanoparticle, folic acid, glucose, insulin, unclassified drug, animal experiment, animal model, antidiabetic activity, Article, Caco-2 cell line, cell viability, controlled study, cytotoxicity, enzymatic degradation, glucose blood level, histopathology, human, human cell, in vivo study, insulin blood level, insulin release, internalization, intestine mucosa permeability, male, mean residence time, nonhuman, particle size, pH, priority journal, rat, zeta potential